Novo Nordisk’s $1.3 Billion Acquisition of Ocedurenone

Sonia Carcano
Tagged:

KBP Biosciences was represented by Goodwin Procter LLP and Novo Nordisk was represented by Covington & Burling LLP in this transaction.Novo Nordisk A/S and KBP Biosciences…

This content is for Standard 1 Year members only.
Login Join Now
Sonia Carcano

Author: Sonia Carcano

…

This content is for Standard 1 Year members only.
Login Join Now